Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e95b861c9a0185a42f811471302139aa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
filingDate |
2005-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499742992fb3fe9783f829164fecdd1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_851786d5ef4b129fa3f6cd759fa8c36a |
publicationDate |
2007-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1814541-A2 |
titleOfInvention |
Stable atorvastatin formulations |
abstract |
A simple yet efficient formulation for providing excellent bioefficacy, wherein the formulation comprises atorvastatin or a salt thereof, optionally in a crystalline or amorphous form, wherein at least one pharmaceutical excipient is selected according to a form of atorvastatin, for example for greater stability. Preferably the formulation lacks a stabilizer. |
priorityDate |
2004-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |